These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Pharmacotherapy of severe heart failure with inodilators--new approaches]. Baumann G; Hader O Z Kardiol; 1996; 85 Suppl 4():9-19. PubMed ID: 9027110 [TBL] [Abstract][Full Text] [Related]
6. [Chronic heart failure: improvement of the prognosis by therapy?]. Drexler H Herz; 1990 Jun; 15(3):214-21. PubMed ID: 1973916 [TBL] [Abstract][Full Text] [Related]
7. The role of novel inotropic agents in the treatment of heart failure. LeJemtel TH; Keren G; Reis D; Sonnenblick EH J Cardiovasc Pharmacol; 1986; 8 Suppl 9():S47-54. PubMed ID: 2433542 [TBL] [Abstract][Full Text] [Related]
8. [New positive inotropic drugs in acute and chronic heart failure]. Follath F Schweiz Rundsch Med Prax; 1992 May; 81(21):704-7. PubMed ID: 1351309 [TBL] [Abstract][Full Text] [Related]
9. [Positive inotropic substances in therapy of heart failure: digitalis, catecholamines, phosphodiesterase inhibitors]. Stefenelli T Acta Med Austriaca; 1991; 18(4):81-5. PubMed ID: 1763582 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of chronic heart failure with positive inotropic agents]. Lechat P Therapie; 1989; 44(6):437-45. PubMed ID: 2576155 [TBL] [Abstract][Full Text] [Related]
11. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure. Weber KT; Janicki JS; Jain MC J Heart Transplant; 1986; 5(2):105-12. PubMed ID: 2956397 [TBL] [Abstract][Full Text] [Related]
12. Rationale and design of the enoximone clinical trials program. Lowes BD; Shakar SF; Metra M; Feldman AM; Eichhorn E; Freytag JW; Gerber MJ; Liard JF; Hartman C; Gorczynski R; Evans G; Linseman JV; Stewart J; Robertson AD; Roecker EB; Demets DL; Bristow MR J Card Fail; 2005 Dec; 11(9):659-69. PubMed ID: 16360960 [TBL] [Abstract][Full Text] [Related]
13. [Drug therapy of heart failure]. Follath F Ther Umsch; 1993 Jun; 50(6):425-33. PubMed ID: 8351674 [TBL] [Abstract][Full Text] [Related]
14. Physiologic determinants of survival in congestive heart failure. The survival hypothesis: how small uncontrolled studies should influence the design of large-scale clinical trials. Francis GS Circulation; 1987 May; 75(5 Pt 2):IV74-9. PubMed ID: 3568319 [TBL] [Abstract][Full Text] [Related]
15. [Ibopamine--clinical results]. Kleber FX Z Kardiol; 1991; 80 Suppl 8():71-6. PubMed ID: 1686695 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of chronic heart failure in the child]. Bonnet D Arch Pediatr; 2001 Dec; 8(12):1379-82. PubMed ID: 11811037 [TBL] [Abstract][Full Text] [Related]
17. Chronic therapy of severe heart failure with enoximone. Gilfrich HJ; Witzke-Gross J; Römer A J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S75-7. PubMed ID: 2480490 [TBL] [Abstract][Full Text] [Related]
18. [Trends in pharmacological treatment of congestive heart failure]. Halawa B Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602 [TBL] [Abstract][Full Text] [Related]